Literature DB >> 371412

Immunogenetic aspects of intracerebral skin transplantation in inbred rats.

S J Geyer, T J Gill.   

Abstract

This study was undertaken to evaluate the ability of intracerebral skin grafts transplanted across different genetic disparities in the major histocompatibility complex (RT1) to elicit an immune response in inbred rats, as determined by histologic examination and by the ability of the grafts to sensitize the recipients to subsequent orthotopic skin grafts. The ability of intracerebral skin allografts to sensitize rats to transplantation antigens is related to the specific genetic disparity between the graft and the host: sensitization appears to occur more consistently across an A region barrier than across a B region barrier. Histologic changes of intracerebral graft rejection are more severe in rats with two intracerebral grafts than in those with one. The degree of histologic change attributable to intracerebral allograft rejection correlates with the ability of these grafts to sensitize the recipient. In certain strains intracerebral sensitization is accomplished with two grafts but not with one, indicating an antigenic dose requirement for intracerebral sensitization.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 371412      PMCID: PMC2042272     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  IS THE BRAIN "AN IMMUNOLOGICALLY PRIVILEGED SITE"?I. STUDIES BASED ON INTRACEREBRAL TUMOR HOMOTRANSPLANTATION AND ISOTRANSPLANTATION TO SENSITIZED HOSTS.

Authors:  L C SCHEINBERG; F L EDELMAN; W A LEVY
Journal:  Arch Neurol       Date:  1964-09

2.  STUDIES ON HOMOGRAFTS OF FOETAL AND INFANT SKIN AND FURTHER OBSERVATIONS ON THE ANOMALOUS PROPERTIES OF POUCH SKIN GRAFTS IN HAMSTERS.

Authors:  R E BILLINGHAM; W K SILVERS
Journal:  Proc R Soc Lond B Biol Sci       Date:  1964-12-15

3.  BELLMAN S, FARNSWORTH D: THE ROLE OF THE LYMPH TRUNKS IN THE RESPONSE TO ALLOGENEIC SKIN TRANSPLANTS.

Authors:  P B LAMBERT; H A FRANK
Journal:  Transplantation       Date:  1965-01       Impact factor: 4.939

4.  Studies on the role of antibodies in the failure of homografts.

Authors:  G A VOISIN; P MAUER
Journal:  Ann N Y Acad Sci       Date:  1957-03-22       Impact factor: 5.691

5.  Heterotransplantation of tumors.

Authors:  H S GREENE
Journal:  Ann N Y Acad Sci       Date:  1957-12-16       Impact factor: 5.691

6.  Passive transfer of transplantation immunity.

Authors:  N A MITCHISON
Journal:  Proc R Soc Lond B Biol Sci       Date:  1954-02-18

7.  The transplantation of human brain tumors to the brains of laboratory animals.

Authors:  H S GREENE
Journal:  Cancer Res       Date:  1953-06       Impact factor: 12.701

8.  The fate of skin homografts in man.

Authors:  T Gibson; P B Medawar
Journal:  J Anat       Date:  1943-07       Impact factor: 2.610

9.  THE ROLE OF LYMPHOCYTES IN THE SENSITIZATION OF RATS TO RENAL HOMOGRAFTS.

Authors:  S STROBER; J L GOWANS
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

10.  Studies on the immunological response to foreign tumor transplants in the mouse. I. The role of lymph node cells in conferring immunity by adoptive transfer.

Authors:  N A MITCHISON
Journal:  J Exp Med       Date:  1955-08-01       Impact factor: 14.307

View more
  3 in total

1.  Survival and immunogenicity of dissociated allogeneic fetal neural dopamine-rich grafts when implanted into the brains of adult mice.

Authors:  H Widner; P Brundin; A Björklund; E Möller
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

2.  Xenografting of fetal mouse hippocampal tissue to the brain of adult rats: effects of cyclosporin A treatment.

Authors:  B Finsen; P H Poulsen; J Zimmer
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

Review 3.  Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis.

Authors:  H Widner; P Brundin
Journal:  Brain Res       Date:  1988-11       Impact factor: 3.252

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.